Event-Driven Stocks

Cellular Biomedicine Group, Inc.

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

Signs● 1 good● 5 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY19FY18FY17FY16FY15FY14
Revenue$49,265$50,961$336,817$627,930$2.5M$564,377
Operating income−$9.4M−$8.5M−$27.6M−$28.4M−$20.8M−$12.4M
Net income−$9.3M−$8.5M−$25.5M−$28.2M−$19.4M−$15.5M
Total assets$97.3M$107.6M$61.2M$68.6M$49.5M$43.7M
Total liabilities$41.6M$22.4M$3.9M$2.7M$3.1M$4.5M
Equity$55.7M$85.2M$57.3M$65.9M$46.4M$39.2M
EPS (diluted)——$-0.43$-0.35$-1.70$-1.79
Shares out.18.1M17.0M14.3M12.0M11.0M7.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2019
Operating margin
−19114.8%
Net margin
−18952.2%
Return on equity
−16.8%
Return on assets
−9.6%
Return on capital (ROCE)
−12.8%
Liabilities / assets
42.8%
Debt / equity
0.75×
Book value / share
$3.08
Revenue growth (YoY)
−3.3%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2019
Altman Z″ (distress)
-5.24distress
Accruals / assets
31.1%high accruals
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
22
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 0Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 5 warning● 1 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Conservative leverage (liabilities < 50% of assets)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)